AveXis to Advance Gene Therapy Program Initiated by the Rett Syndrome...

The Rett Syndrome Research Trust (RSRT) is excited to announce that AveXis, Inc., has committed to advance a gene therapy candidate for Rett Syndrome into human clinical trials.(PRWeb June 08, 2017)Read the full story at http://www.prweb.com/releases/2017/06/prweb14408379.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news